Shares of TNL Mediagene – Ordinary Shares (NASDAQ:TNMG – Get Free Report) shot up 2.1% on Thursday . The stock traded as high as $0.74 and last traded at $0.73. 236,307 shares changed hands during trading, a decline of 91% from the average session volume of 2,488,794 shares. The stock had previously closed at $0.71.
Wall Street Analyst Weigh In
Separately, Benchmark initiated coverage on shares of TNL Mediagene – Ordinary Shares in a report on Tuesday, May 20th. They set a “speculative buy” rating and a $3.50 price objective on the stock.
Read Our Latest Analysis on TNL Mediagene – Ordinary Shares
TNL Mediagene – Ordinary Shares Trading Up 2.1%
Institutional Trading of TNL Mediagene – Ordinary Shares
An institutional investor recently bought a new position in TNL Mediagene – Ordinary Shares stock. Mizuho Securities Co. Ltd. acquired a new stake in TNL Mediagene – Ordinary Shares (NASDAQ:TNMG – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 168,298 shares of the company’s stock, valued at approximately $128,000. TNL Mediagene – Ordinary Shares makes up approximately 1.5% of Mizuho Securities Co. Ltd.’s portfolio, making the stock its 21st biggest position. Mizuho Securities Co. Ltd. owned 2.56% of TNL Mediagene – Ordinary Shares at the end of the most recent quarter.
TNL Mediagene – Ordinary Shares Company Profile
TNL Mediagene engages in digital advertising, integrated marketing, marketing survey, artificial intelligence technology, data analysis, content service platform, and production of audio-visual programs. It operates media, technology, and digital studio businesses primarily in Japan and Taiwan. The company was founded on May 25, 2023 and is headquartered in Taipei, Taiwan.
Recommended Stories
- Five stocks we like better than TNL Mediagene – Ordinary Shares
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Stocks Set to Double—And There’s Still Time to Buy
- How to Use Stock Screeners to Find Stocks
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for TNL Mediagene - Ordinary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TNL Mediagene - Ordinary Shares and related companies with MarketBeat.com's FREE daily email newsletter.